BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17276356)

  • 1. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.
    Hughes AL; Powell DW; Bard M; Eckstein J; Barbuch R; Link AJ; Espenshade PJ
    Cell Metab; 2007 Feb; 5(2):143-9. PubMed ID: 17276356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A helping hand for cytochrome p450 enzymes.
    Debose-Boyd RA
    Cell Metab; 2007 Feb; 5(2):81-3. PubMed ID: 17276348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
    Ahmed IS; Chamberlain C; Craven RJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51.
    Craven RJ; Mallory JC; Hand RA
    J Biol Chem; 2007 Dec; 282(50):36543-51. PubMed ID: 17954932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner.
    Oda S; Nakajima M; Toyoda Y; Fukami T; Yokoi T
    Drug Metab Dispos; 2011 Nov; 39(11):2057-65. PubMed ID: 21825115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism.
    McGuire MR; Mukhopadhyay D; Myers SL; Mosher EP; Brookheart RT; Kammers K; Sehgal A; Selen ES; Wolfgang MJ; Bumpus NN; Espenshade PJ
    J Biol Chem; 2021 Nov; 297(5):101316. PubMed ID: 34678314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
    Rohe HJ; Ahmed IS; Twist KE; Craven RJ
    Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase.
    Szczesna-Skorupa E; Kemper B
    Mol Pharmacol; 2011 Mar; 79(3):340-50. PubMed ID: 21081644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands.
    Cahill MA; Medlock AE
    J Steroid Biochem Mol Biol; 2017 Jul; 171():11-33. PubMed ID: 28104494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystathionine β-synthase and PGRMC1 as CO sensors.
    Kabe Y; Yamamoto T; Kajimura M; Sugiura Y; Koike I; Ohmura M; Nakamura T; Tokumoto Y; Tsugawa H; Handa H; Kobayashi T; Suematsu M
    Free Radic Biol Med; 2016 Oct; 99():333-344. PubMed ID: 27565814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic and mutagenesis studies of human PGRMC1.
    Kaluka D; Batabyal D; Chiang BY; Poulos TL; Yeh SR
    Biochemistry; 2015 Mar; 54(8):1638-47. PubMed ID: 25675345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins.
    Kimura I; Nakayama Y; Konishi M; Terasawa K; Ohta M; Itoh N; Fujimoto M
    Curr Protein Pept Sci; 2012 Nov; 13(7):687-96. PubMed ID: 23228349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.
    Mansouri MR; Schuster J; Badhai J; Stattin EL; Lösel R; Wehling M; Carlsson B; Hovatta O; Karlström PO; Golovleva I; Toniolo D; Bione S; Peluso J; Dahl N
    Hum Mol Genet; 2008 Dec; 17(23):3776-83. PubMed ID: 18782852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.
    Ahmed IS; Rohe HJ; Twist KE; Mattingly MN; Craven RJ
    J Pharmacol Exp Ther; 2010 May; 333(2):564-73. PubMed ID: 20164297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYB5D2 requires heme-binding to regulate HeLa cell growth and confer survival from chemotherapeutic agents.
    Bruce A; Rybak AP
    PLoS One; 2014; 9(1):e86435. PubMed ID: 24466094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1.
    Bureik M; Schiffler B; Hiraoka Y; Vogel F; Bernhardt R
    Biochemistry; 2002 Feb; 41(7):2311-21. PubMed ID: 11841224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGRMC2, a yet uncharacterized protein with potential as tumor suppressor, migration inhibitor, and regulator of cytochrome P450 enzyme activity.
    Wendler A; Wehling M
    Steroids; 2013 Jun; 78(6):555-8. PubMed ID: 23276631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGRMC1: An enigmatic heme-binding protein.
    McGuire MR; Espenshade PJ
    Pharmacol Ther; 2023 Jan; 241():108326. PubMed ID: 36463977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae.
    Mallory JC; Crudden G; Johnson BL; Mo C; Pierson CA; Bard M; Craven RJ
    Mol Cell Biol; 2005 Mar; 25(5):1669-79. PubMed ID: 15713626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450.
    Ryu CS; Klein K; Zanger UM
    Front Pharmacol; 2017; 8():159. PubMed ID: 28396637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.